{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T17:50:11Z","timestamp":1786989011541,"version":"build-2736575974"},"reference-count":52,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100004837","name":"Spanish Ministry of Science and Innovation","doi-asserted-by":"crossref","award":["PI15\/00283"],"award-info":[{"award-number":["PI15\/00283"]}],"id":[{"id":"10.13039\/501100004837","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100004837","name":"Spanish Ministry of Science and Innovation","doi-asserted-by":"crossref","award":["PI18\/00805"],"award-info":[{"award-number":["PI18\/00805"]}],"id":[{"id":"10.13039\/501100004837","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100008530","name":"FEDER","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100008530","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100006751","name":"CIBERSAM","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100006751","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Secretaria d'Universitats i Recerca del Departament d'Economia i Coneixement","award":["2017"],"award-info":[{"award-number":["2017"]}]},{"DOI":"10.13039\/501100010552","name":"Departament de Salut de la Generalitat de Catalunya","doi-asserted-by":"crossref","award":["SLT006\/17\/00357"],"award-info":[{"award-number":["SLT006\/17\/00357"]}],"id":[{"id":"10.13039\/501100010552","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Neuropsychopharmacology"],"published-print":{"date-parts":[[2020,12]]},"DOI":"10.1016\/j.euroneuro.2020.09.635","type":"journal-article","created":{"date-parts":[[2020,10,16]],"date-time":"2020-10-16T13:47:53Z","timestamp":1602856073000},"page":"16-27","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"special_numbering":"C","title":["Aripiprazole monotherapy as transdiagnostic intervention for the treatment of mental disorders: An umbrella review according to TRANSD criteria"],"prefix":"10.1016","volume":"41","author":[{"given":"Marco","family":"Solmi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luca","family":"Bodini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susanna","family":"Cocozza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary V.","family":"Seeman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eduard","family":"Vieta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Dragioti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andre F.","family":"Carvalho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paolo","family":"Fusar-Poli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.euroneuro.2020.09.635_bib0001","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1186\/s13063-017-1859-x","article-title":"Methods of defining the non-inferiority margin in randomized, double-blind controlled trials: a systematic review","volume":"18","author":"Althunian","year":"2017","journal-title":"Trials"},{"key":"10.1016\/j.euroneuro.2020.09.635_bib0002","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.jad.2020.03.030","article-title":"Comparative efficacy and tolerability of pharmacological treatments for the treatment of acute bipolar depression: a systematic review and network meta-analysis","volume":"269","author":"Bahji","year":"2020","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.euroneuro.2020.09.635_bib0003","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.maturitas.2014.05.009","article-title":"Depression and dementia: cause, consequence or coincidence?","volume":"79","author":"Bennett","year":"2014","journal-title":"Maturitas"},{"key":"10.1016\/j.euroneuro.2020.09.635_bib0004","doi-asserted-by":"crossref","DOI":"10.2174\/1567205017666200217104114","article-title":"Depression in dementia or dementia in depression? Systematic review of studies and hypotheses","author":"Brzezi\u0144ska","year":"2020","journal-title":"Curr. Alzheimer Res."},{"key":"10.1016\/j.euroneuro.2020.09.635_bib0005","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1056\/NEJMra1906193","article-title":"Bipolar disorder","volume":"383","author":"Carvalho","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.euroneuro.2020.09.635_bib0006","doi-asserted-by":"crossref","first-page":"3127","DOI":"10.1002\/1097-0258(20001130)19:22<3127::AID-SIM784>3.0.CO;2-M","article-title":"A simple method for converting an odds ratio to effect size for use in meta-analysis","volume":"19","author":"Chinn","year":"2000","journal-title":"Stat. Med."},{"key":"10.1016\/j.euroneuro.2020.09.635_bib0007","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.jamda.2019.10.022","article-title":"Adverse outcomes of polypharmacy in older people: systematic review of reviews","volume":"21","author":"Davies","year":"2020","journal-title":"J. Am. Med. Dir. Assoc."},{"key":"10.1016\/j.euroneuro.2020.09.635_bib0008","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1177\/0269881117744996","article-title":"Sequential drug treatment algorithm for agitation and aggression in Alzheimer's and mixed dementia","volume":"32","author":"Davies","year":"2018","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.euroneuro.2020.09.635_bib0009","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.cger.2019.11.008","article-title":"Older age bipolar disorder","volume":"36","author":"Dols","year":"2020","journal-title":"Clin. Geriatr. Med."},{"key":"10.1016\/j.euroneuro.2020.09.635_bib0010","doi-asserted-by":"crossref","DOI":"10.1002\/wps.20681","article-title":"TRANSD recommendations: improving transdiagnostic research in psychiatry","author":"Fusar-Poli","year":"2019","journal-title":"World Psychiatry"},{"key":"10.1016\/j.euroneuro.2020.09.635_bib0011","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1002\/wps.20631","article-title":"Transdiagnostic psychiatry: a systematic review","volume":"18","author":"Fusar-Poli","year":"2019","journal-title":"World Psychiatry"},{"key":"10.1016\/j.euroneuro.2020.09.635_bib0012","doi-asserted-by":"crossref","DOI":"10.1038\/nature25753","article-title":"Meta-analysis and the science of research synthesis","author":"Gurevitch","year":"2018","journal-title":"Nature"},{"key":"10.1016\/j.euroneuro.2020.09.635_bib0013","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.1017\/S0033291712002449","article-title":"Age of major depression onset, depressive symptoms, and risk for subsequent dementia: results of the German Study on Ageing, Cognition, and Dementia in Primary Care Patients (AgeCoDe)","volume":"43","author":"Heser","year":"2013","journal-title":"Psychol. Med."},{"key":"10.1016\/j.euroneuro.2020.09.635_bib0014","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1016\/S0140-6736(19)31135-3","article-title":"Comparative efficacy and tolerability of 32 oral antipsychotics for the acute treatment of adults with multi-episode schizophrenia: a systematic review and network meta-analysis","volume":"394","author":"Huhn","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/j.euroneuro.2020.09.635_bib0015","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1080\/09540261.2017.1397606","article-title":"Molecular imaging of autism spectrum disorder","volume":"29","author":"Hwang","year":"2017","journal-title":"Int. Rev. Psychiatry"},{"key":"10.1016\/j.euroneuro.2020.09.635_bib0016","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.3233\/JAD-190954","article-title":"In vivo MRI structural and PET metabolic connectivity study of dopamine pathways in Alzheimer's disease","volume":"75","author":"Iaccarino","year":"2020","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.euroneuro.2020.09.635_bib0017","doi-asserted-by":"crossref","unstructured":"Pillay J, Boylan K, Carrey N, Newton A, Vandermeer B, Nuspl M, MacGregor T, Jafri SHA, Featherstone R, Hartling L2017a. First- and Second-Generation Antipsychotics in Children and Young Adults: Systematic Review Update [Internet].","DOI":"10.1177\/0706743718779950"},{"key":"10.1016\/j.euroneuro.2020.09.635_bib0018","doi-asserted-by":"crossref","unstructured":"Pillay J, Boylan K, Carrey N, Newton A, Vandermeer B, Nuspl M, MacGregor T, Jafri SHA, Featherstone R, Hartling L, 2017b. First- and Second-Generation Antipsychotics in Children and Young Adults: Systematic Review Update [Internet].","DOI":"10.1177\/0706743718779950"},{"key":"10.1016\/j.euroneuro.2020.09.635_bib0019","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1001\/jamapsychiatry.2017.2943","article-title":"A test of the transdiagnostic dopamine hypothesis of psychosis using positron emission tomographic imaging in bipolar affective disorder and schizophrenia","volume":"74","author":"Jauhar","year":"2017","journal-title":"JAMA Psychiatry"},{"key":"10.1016\/j.euroneuro.2020.09.635_bib0020","doi-asserted-by":"crossref","unstructured":"Kishi, T., Ikuta, T., Matsuda, Y., Sakuma, K., Iwata Taro; ORCID: http:\/\/orcid.org\/0000-0002-9237-2236, N.A.I.-O. http:\/\/orcid. org\/Kish., 2020a. Aripiprazole vs. Brexpiprazole for acute schizophrenia: A systematic review and network meta-analysis. Psychopharmacology (Berl)., Psychopharmacologia No-Specified. doi:10.1007\/s00213-020-05472-5.","DOI":"10.1007\/s00213-020-05472-5"},{"key":"10.1016\/j.euroneuro.2020.09.635_bib0021","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1007\/s00213-020-05472-5","article-title":"Aripiprazole vs. brexpiprazole for acute schizophrenia: a systematic review and network meta-analysis","volume":"237","author":"Kishi","year":"2020","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.euroneuro.2020.09.635_bib0022","article-title":"Antipsychotics for cocaine or psychostimulant dependence: systematic review and meta-analysis of randomized, placebo-controlled trials","author":"Kishi","year":"2013","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.euroneuro.2020.09.635_bib0023","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1001\/archpsyc.1967.01730190120016","article-title":"Importance of psychiatric diagnosis in prediction of clinical drug effects","volume":"16","author":"Klein","year":"1967","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.euroneuro.2020.09.635_bib0024","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1007\/s00787-014-0576-1","article-title":"Determination of psychosis-related clinical profiles in children with autism spectrum disorders using latent class analysis","volume":"24","author":"Kyriakopoulos","year":"2015","journal-title":"Eur. Child Adolesc. Psychiatry"},{"key":"10.1016\/j.euroneuro.2020.09.635_bib0025","doi-asserted-by":"crossref","DOI":"10.1016\/j.pnpbp.2017.06.023","article-title":"Efficacy, safety and tolerability of aripiprazole in bipolar disorder: an updated systematic review and meta-analysis of randomized controlled trials","volume":"79","author":"Li","year":"2017","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.euroneuro.2020.09.635_bib0026","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1000100","article-title":"The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration","author":"Liberati","year":"2009","journal-title":"PLoS Med."},{"key":"10.1016\/j.euroneuro.2020.09.635_bib0027","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1001\/jama.288.12.1475","article-title":"Prevalence of neuropsychiatric symptoms in dementia and mild cognitive impairment: Results from the cardiovascular health study","volume":"288","author":"Lyketsos","year":"2002","journal-title":"J. Am. Med. Assoc."},{"key":"10.1016\/j.euroneuro.2020.09.635_bib0028","doi-asserted-by":"crossref","first-page":"3063","DOI":"10.2147\/NDT.S174622","article-title":"Aripiprazole in acute treatment of children and adolescents with autism spectrum disorder: a systematic review and meta-analysis","volume":"14","author":"Maneeton","year":"2018","journal-title":"Neuropsychiatr. Dis. Treat."},{"key":"10.1016\/j.euroneuro.2020.09.635_bib0029","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1002\/wps.20680","article-title":"Transdiagnostic psychiatry goes above and beyond classification","volume":"18","author":"Mansell","year":"2019","journal-title":"World Psychiatry"},{"key":"10.1016\/j.euroneuro.2020.09.635_bib0030","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2011-0427","article-title":"A systematic review of medical treatments for children with autism spectrum disorders","volume":"127","author":"McPheeters","year":"2011","journal-title":"Pediatrics"},{"key":"10.1016\/j.euroneuro.2020.09.635_bib0031","doi-asserted-by":"crossref","DOI":"10.1007\/s00406-016-0699-0","article-title":"Neuroscience-based nomenclature (jNbN) to replace traditional terminology of psychotropic medications","author":"M\u00f6ller","year":"2016","journal-title":"Eur. Arch. Psychiatry Clin. Neurosci."},{"key":"10.1016\/j.euroneuro.2020.09.635_bib0032","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1017\/S1041610217001909","article-title":"Prevalence estimates of mild behavioral impairment in a population-based sample of pre-dementia states and cognitively healthy older adults","volume":"30","author":"Mortby","year":"2018","journal-title":"Int. Psychogeriatr."},{"key":"10.1016\/j.euroneuro.2020.09.635_bib0033","unstructured":"NbN2r - Neuroscience Based Nomenclature, S.E.-R.N.B., 2020. https:\/\/nbn2r.com\/authors[WWW Document]."},{"key":"10.1016\/j.euroneuro.2020.09.635_bib0034","article-title":"Aripiprazole (intramuscular) for psychosis-induced aggression or agitation (rapid tranquillisation) (Review) SUMMARY OF FINDINGS FOR THE MAIN COMPARISON","author":"Ostinelli","year":"2018","journal-title":"Cochrane Datab. Syst. Rev."},{"key":"10.1016\/j.euroneuro.2020.09.635_bib0035","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1001\/archpsyc.1995.03950180057008","article-title":"In vivo D2 dopamine receptor density in psychotic and nonpsychotic patients with bipolar disorder","volume":"52","author":"Pearlson","year":"1995","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.euroneuro.2020.09.635_bib0036","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0234514","article-title":"Behavioural issues in late life may be the precursor of dementia \u2013 a cross sectional evidence from memory clinic of AIIMS, India","volume":"15","author":"Rao","year":"2020","journal-title":"PLoS One"},{"key":"10.1016\/j.euroneuro.2020.09.635_bib0037","doi-asserted-by":"crossref","DOI":"10.1007\/s40261-019-00801-9","article-title":"Long-Acting Injectable (LAI) Aripiprazole formulations in the treatment of schizophrenia and bipolar disorder: a systematic review","author":"Rapinesi","year":"2019","journal-title":"Clin. Drug Investig."},{"key":"10.1016\/j.euroneuro.2020.09.635_bib0038","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1136\/bmj.d549","article-title":"Interpretation of random effects meta-analyses","volume":"342","author":"Riley","year":"2011","journal-title":"BMJ"},{"key":"10.1016\/j.euroneuro.2020.09.635_bib0039","doi-asserted-by":"crossref","DOI":"10.1177\/0269881118760661","article-title":"Meta-analysis and review of dopamine agonists in acute episodes of mood disorder: efficacy and safety","author":"Romeo","year":"2018","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.euroneuro.2020.09.635_bib0040","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1111\/bdi.12331","article-title":"A report on older-age bipolar disorder from the International Society for Bipolar Disorders Task Force","volume":"17","author":"Sajatovic","year":"2015","journal-title":"Bipolar Disord."},{"key":"10.1016\/j.euroneuro.2020.09.635_bib0041","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1016\/j.jpsychires.2006.04.008","article-title":"Psychopathology factors in first-episode affective and non-affective psychotic disorders","volume":"41","author":"Salvatore","year":"2007","journal-title":"J. Psychiatr. Res."},{"key":"10.1016\/j.euroneuro.2020.09.635_bib0042","doi-asserted-by":"crossref","first-page":"4008","DOI":"10.1136\/bmj.j4008","article-title":"AMSTAR 2: a critical appraisal tool for systematic reviews that include randomised or non-randomised studies of healthcare interventions, or both","volume":"358","author":"Shea","year":"2017","journal-title":"BMJ"},{"key":"10.1016\/j.euroneuro.2020.09.635_bib0043","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1002\/wps.20765","article-title":"Safety of 80 antidepressants, antipsychotics, anti\u2010attention\u2010deficit\/hyperactivity medications and mood stabilizers in children and adolescents with psychiatric disorders: a large scale systematic meta\u2010review of 78 adverse effects","volume":"19","author":"Solmi","year":"2020","journal-title":"World Psychiatry"},{"key":"10.1016\/j.euroneuro.2020.09.635_bib0044","doi-asserted-by":"crossref","DOI":"10.2147\/TCRM.S117321","article-title":"Safety, tolerability, and risks associated with first-and second-generation antipsychotics: a state-of-the-art clinical review","author":"Solmi","year":"2017","journal-title":"Ther. Clin. Risk Manag."},{"key":"10.1016\/j.euroneuro.2020.09.635_bib0045","doi-asserted-by":"crossref","first-page":"548","DOI":"10.3389\/fpsyt.2020.00548","article-title":"Autism spectrum disorder and schizophrenia are better differentiated by positive symptoms than negative symptoms","volume":"11","author":"Trevisan","year":"2020","journal-title":"Front. Psychiatry"},{"key":"10.1016\/j.euroneuro.2020.09.635_bib0046","doi-asserted-by":"crossref","DOI":"10.1136\/jnnp-2014-308112","article-title":"Pharmacological treatment of neuropsychiatric symptoms in Alzheimer's disease: a systematic review and meta-analysis","author":"Wang","year":"2015","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.euroneuro.2020.09.635_bib0047","doi-asserted-by":"crossref","DOI":"10.1016\/S2215-0366(17)30098-6","article-title":"Neuroscience-based nomenclature (NbN)","author":"Worley","year":"2017","journal-title":"Lancet Psychiatry"},{"key":"10.1016\/j.euroneuro.2020.09.635_bib0048","doi-asserted-by":"crossref","first-page":"e15816","DOI":"10.1097\/MD.0000000000015816","article-title":"Safety of aripiprazole for tics in children and adolescents: a systematic review and meta-analysis","volume":"98","author":"Yang","year":"2019","journal-title":"Medicine."},{"key":"10.1016\/j.euroneuro.2020.09.635_bib0049","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1111\/bdi.12609","article-title":"Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) 2018 guidelines for the management of patients with bipolar disorder","volume":"20","author":"Yatham","year":"2018","journal-title":"Bipolar Disord."},{"key":"10.1016\/j.euroneuro.2020.09.635_bib0050","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.pnpbp.2018.12.009","article-title":"Augmentation agents to serotonin reuptake inhibitors for treatment-resistant obsessive-compulsive disorder: a network meta-analysis","volume":"90","author":"Zhou","year":"2019","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry Progr. Neuro-Psychopharmacol."},{"key":"10.1016\/j.euroneuro.2020.09.635_bib0051","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/ijnp\/pyv060","article-title":"Atypical antipsychotic augmentation for treatment-resistant depression: a systematic review and network meta-analysis","volume":"18","author":"Zhou","year":"2015","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.euroneuro.2020.09.635_bib0052","doi-asserted-by":"crossref","first-page":"2318","DOI":"10.1016\/j.euroneuro.2015.08.019","article-title":"A review of the current nomenclature for psychotropic agents and an introduction to the Neuroscience-based Nomenclature","volume":"25","author":"Zohar","year":"2015","journal-title":"Eur. Neuropsychopharmacol."}],"container-title":["European Neuropsychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924977X20309081?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924977X20309081?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,13]],"date-time":"2025-10-13T17:58:16Z","timestamp":1760378296000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0924977X20309081"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12]]},"references-count":52,"alternative-id":["S0924977X20309081"],"URL":"https:\/\/doi.org\/10.1016\/j.euroneuro.2020.09.635","relation":{},"ISSN":["0924-977X"],"issn-type":[{"value":"0924-977X","type":"print"}],"subject":[],"published":{"date-parts":[[2020,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Aripiprazole monotherapy as transdiagnostic intervention for the treatment of mental disorders: An umbrella review according to TRANSD criteria","name":"articletitle","label":"Article Title"},{"value":"European Neuropsychopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.euroneuro.2020.09.635","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier B.V. and ECNP. All rights reserved.","name":"copyright","label":"Copyright"}]}}